🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Online Trading Operations

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly serious medical dangers”.